1036 related articles for article (PubMed ID: 25981488)
1. Incidence, direct costs and duration of hospitalization of patients hospitalized with community acquired pneumonia: A nationwide retrospective claims database analysis.
Rozenbaum MH; Mangen MJ; Huijts SM; van der Werf TS; Postma MJ
Vaccine; 2015 Jun; 33(28):3193-9. PubMed ID: 25981488
[TBL] [Abstract][Full Text] [Related]
2. CAPECO: Cost evaluation of community acquired pneumonia managed in primary care.
Personne V; Chevalier J; Buffel du Vaure C; Partouche H; Gilberg S; de Pouvourville G
Vaccine; 2016 Apr; 34(19):2275-80. PubMed ID: 26979138
[TBL] [Abstract][Full Text] [Related]
3. Clinical and economic burden of community-acquired pneumonia in the Veterans Health Administration, 2011: a retrospective cohort study.
McLaughlin JM; Johnson MH; Kagan SA; Baer SL
Infection; 2015 Dec; 43(6):671-80. PubMed ID: 25980561
[TBL] [Abstract][Full Text] [Related]
4. Burden of hospitalized childhood community-acquired pneumonia: A retrospective cross-sectional study in Vietnam, Malaysia, Indonesia and the Republic of Korea.
Tan KK; Dang DA; Kim KH; Kartasasmita C; Kim HM; Zhang XH; Shafi F; Yu TW; Ledesma E; Meyer N
Hum Vaccin Immunother; 2018 Jan; 14(1):95-105. PubMed ID: 29125809
[TBL] [Abstract][Full Text] [Related]
5. Potential for cost-savings in the care of hospitalized low-risk community-acquired pneumonia patients in China.
Zhou QT; He B; Zhu H
Value Health; 2009; 12(1):40-6. PubMed ID: 18637052
[TBL] [Abstract][Full Text] [Related]
6. Estimating the economic impact of a half-day reduction in length of hospital stay among patients with community-acquired pneumonia in the US.
Raut M; Schein J; Mody S; Grant R; Benson C; Olson W
Curr Med Res Opin; 2009 Sep; 25(9):2151-7. PubMed ID: 19601711
[TBL] [Abstract][Full Text] [Related]
7. Hospitalization costs for community-acquired pneumonia in Dutch elderly: an observational study.
Vissink CE; Huijts SM; de Wit GA; Bonten MJ; Mangen MJ
BMC Infect Dis; 2016 Sep; 16(1):466. PubMed ID: 27589847
[TBL] [Abstract][Full Text] [Related]
8. Community-acquired pneumonia episode costs by age and risk in commercially insured US adults aged ≥50 years.
Sato R; Gomez Rey G; Nelson S; Pinsky B
Appl Health Econ Health Policy; 2013 Jun; 11(3):251-8. PubMed ID: 23605251
[TBL] [Abstract][Full Text] [Related]
9. Disease burden of hospitalized community-acquired pneumonia in South Korea: Analysis based on age and underlying medical conditions.
Choi MJ; Song JY; Noh JY; Yoon JG; Lee SN; Heo JY; Yoon JW; Jo YM; Cheong HJ; Kim WJ
Medicine (Baltimore); 2017 Nov; 96(44):e8429. PubMed ID: 29095281
[TBL] [Abstract][Full Text] [Related]
10. Clinical and economic burden of community-acquired pneumonia in the Medicare fee-for-service population.
Yu H; Rubin J; Dunning S; Li S; Sato R
J Am Geriatr Soc; 2012 Nov; 60(11):2137-43. PubMed ID: 23110409
[TBL] [Abstract][Full Text] [Related]
11. Characteristics of Children Hospitalized With Aspiration Pneumonia.
Hirsch AW; Monuteaux MC; Fruchtman G; Bachur RG; Neuman MI
Hosp Pediatr; 2016 Nov; 6(11):659-666. PubMed ID: 27803071
[TBL] [Abstract][Full Text] [Related]
12. The annual economic burden among patients hospitalized for community-acquired pneumonia (CAP): a retrospective US cohort study.
Divino V; Schranz J; Early M; Shah H; Jiang M; DeKoven M
Curr Med Res Opin; 2020 Jan; 36(1):151-160. PubMed ID: 31566005
[No Abstract] [Full Text] [Related]
13. Community-acquired pneumonia on the intensive care unit: secondary analysis of 17,869 cases in the ICNARC Case Mix Programme Database.
Woodhead M; Welch CA; Harrison DA; Bellingan G; Ayres JG
Crit Care; 2006; 10 Suppl 2(Suppl 2):S1. PubMed ID: 16934135
[TBL] [Abstract][Full Text] [Related]
14. Cost and incidence of social comorbidities in low-risk patients with community-acquired pneumonia admitted to a public hospital.
Goss CH; Rubenfeld GD; Park DR; Sherbin VL; Goodman MS; Root RK
Chest; 2003 Dec; 124(6):2148-55. PubMed ID: 14665494
[TBL] [Abstract][Full Text] [Related]
15. The cost of treating community-acquired pneumonia.
Niederman MS; McCombs JS; Unger AN; Kumar A; Popovian R
Clin Ther; 1998; 20(4):820-37. PubMed ID: 9737840
[TBL] [Abstract][Full Text] [Related]
16. Work-related and health care cost burden of community-acquired pneumonia in an employed population.
Kleinman NL; Yu H; Beren IA; Sato R
J Occup Environ Med; 2013 Oct; 55(10):1149-56. PubMed ID: 24064787
[TBL] [Abstract][Full Text] [Related]
17. Economic cost of community-acquired pneumonia in New Zealand adults.
Scott G; Scott H; Turley M; Baker M
N Z Med J; 2004 Jun; 117(1196):U933. PubMed ID: 15280937
[TBL] [Abstract][Full Text] [Related]
18. A comparison of levofloxacin and moxifloxacin use in hospitalized community-acquired pneumonia (CAP) patients in the US: focus on length of stay.
Schein J; Janagap-Benson C; Grant R; Sikirica V; Doshi D; Olson W
Curr Med Res Opin; 2008 Mar; 24(3):895-906. PubMed ID: 18419876
[TBL] [Abstract][Full Text] [Related]
19. Burden of community-acquired pneumonia, predisposing factors and health-care related costs in patients with cancer.
Schmedt N; Heuer OD; Häckl D; Sato R; Theilacker C
BMC Health Serv Res; 2019 Jan; 19(1):30. PubMed ID: 30642312
[TBL] [Abstract][Full Text] [Related]
20. Disease burden of pneumonia in Korean adults aged over 50 years stratified by age and underlying diseases.
Lee JY; Yoo CG; Kim HJ; Jung KS; Yoo KH
Korean J Intern Med; 2014 Nov; 29(6):764-73. PubMed ID: 25378975
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
